未登录

G

Gabriel Glockzin

University of Regensburg

H指数:26

被引数:1,823

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial

CLINICAL COLORECTAL CANCER

IF3.2

2018-12-0135

PREAI

Morbidity and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Data from the DGAV StuDoQ Registry with 2149 Consecutive Patients

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2018-11-1941

PREAI

Total Parathyroidectomy With Routine Thymectomy and Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism: Results of a Nonconfirmatory Multicenter Prospective Randomized Controlled Pilot Trial

甲状旁腺全切除术联合常规胸腺切除和自体移植与单纯甲状旁腺全切除术治疗继发性甲状旁腺功能亢进症: 一项非验证性多中心前瞻性随机对照试验的结果

ANNALS OF SURGERY

IF6.4

2016-11-0163

PREAI

Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells

IF6.3

2016-10-1437

OAAI

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis

IF3.4

2014-11-0424

OAAI

Challenges in the multidisciplinary management of stage IV colon and rectal cancer

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY

IF2.5

2014-09-059

PREAI

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

IF3.4

2013-02-0738

OAAI

Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature

IF3.4

2012-08-1622

OAAI

Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2011-11-08140

OAAI

Hepatobiliary Procedures in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2010-11-0322

PREAI

Safety of Gastric Resections During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2009-05-0236

PREAI

Impact of radiation therapy on the oncolytic adenovirus dl520:: Implications on the treatment of glioblastoma

RADIOTHERAPY AND ONCOLOGY

IF5.3

2008-03-0140

PREAI

Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1α autocrine loop, and reduces orthotopic tumor growth

CLINICAL CANCER RESEARCH

IF10.2

2007-11-01144

PREAI

Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo

MOLECULAR CANCER THERAPEUTICS

IF5.5

2007-03-15119

OAAI

Renal cell carcinoma metastases to the thyroid gland - 8 cases reported

肾细胞癌甲状腺转移8例报告

IF6.7

2007-01-0120

PREAI

Characterization of the recombinant adenovirus vector AdYB-1: Implications for oncolytic vector development

JOURNAL OF VIROLOGY

IF3.8

2006-04-1515

OAAI

Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication:: Impact for cancer gene therapy

CANCER RESEARCH

IF16.6

2004-01-1661

OAAI